SignOnSanDiego.com > News > Business -- Amylin reports $45 million loss

SignOnSanDiego.com > News > Business -- Amylin reports $45 million loss: "Amylin Pharmaceuticals reported a loss of $45 million, or 34 cents a share, for the quarter ended June 30, compared with a loss of $46.4 million, or 38 cents a share, in the same quarter 2006. The company said revenue grew 67 percent to $197 million on increased sales of its diabetes drugs Symlin and Byetta."